Tony Meehan

Chief Business Officer at Venatorx Pharmaceuticals

Dr. Meehan has been working with large public and venture backed start-up pharmaceutical companies for 25 years, including Merck, Johnson & Johnson, and TransForm Pharmaceuticals. Prior to joining Venatorx, Dr. Meehan was Chief Operating Officer of TetraLogic Pharmaceuticals. Tony has played leadership roles across business development, corporate venture, finance, product development, and manufacturing. He has helped raise over $150MM in investment capital, and led teams responsible for the development of over 50 investigational molecules and 8 new product registrations, including GARDISIL®, RotaTeq®, and VIOXX®. Tony holds an M.B.A from the Wharton School of the University of Pennsylvania, a Ph.D. from Carnegie Mellon University and a B.S.E from the University of Pennsylvania.

Links

Timeline

  • Chief Business Officer

    January, 2017 - present

View in org chart